Tirzepatide represents a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://haleemarcbb894470.blogerus.com/62480112/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist